Labels may not always accurately reflect the actual cannabinoid content or concentration.

Delta-8 THC is being researched as a supportive tool in cancer care, particularly for managing the side effects of treatment. While its ability to stimulate appetite and curb nausea offers a potential improvement to patient well-being, it is essential to approach these products with caution. Prioritizing products that offer comprehensive third-party lab testing and consulting with oncology professionals before integration into a care plan is necessary. While the science of cannabinoids continues to evolve, Delta-8 is viewed in the medical community as a supplementary area of study rather than a primary cure.

Without strict oversight, products may contain residual solvents, heavy metals, or unintended levels of other cannabinoids.